[{"orgOrder":0,"company":"Institut de canc\u00e9rologie Strasbourg Europe","sponsor":"LEAF4Life","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"FRANCE","productType":"Plant Extract\/Herbal","year":"2024","type":"Inapplicable","leadProduct":"Transcrocetin Sodium","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase II","graph3":"Institut de canc\u00e9rologie Strasbourg Europe","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Institut de canc\u00e9rologie Strasbourg Europe \/ LEAF4Life","highestDevelopmentStatusID":"8","companyTruncated":"Institut de canc\u00e9rologie Strasbourg Europe \/ LEAF4Life"}]

Find Clinical Drug Pipeline Developments & Deals for Transcrocetin Sodium

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Institut de cancérologie Strasbourg Europe

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          Institut de cancérologie Strasbourg Europe

                          Country arrow
                          AIChE Annual Meeting
                          Not Confirmed

                          Details : Transcrocetin is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Sarcoma.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          June 26, 2024

                          Lead Product(s) : Transcrocetin Sodium

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase II

                          Sponsor : LEAF4Life

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank